The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
A Field Trial to Assess a Blood-Stage Malaria Vaccine
Open accessAbstract
BACKGROUND: Blood-stage malaria vaccines are intended to prevent clinical disease. The malaria vaccine FMP2.1/AS02(A), a recombinant protein based on apical membrane antigen 1 (AMA1) from the 3D7 strain of Plasmodium falciparum, has previously been shown to have immunogenicity and acceptable safety in Malian adults and children. METHODS: In a double-blind, randomized trial, we immunized 400 Malian children with either the malaria vaccine or a control (rabies) vaccine and followed them for 6 months. The primary end point was clinical malaria, defined as fever and at least 2500 parasites per cubic millimeter of blood. A secondary end point was clinical malaria caused by parasites with the AMA1 DNA sequence found in the vaccine strain. RESULTS: The cumulative incidence of the primary end point was 48.4% in the malaria-vaccine group and 54.4% in the control group; efficacy against the primary end point was 17.4% (hazard ratio for the primary end point, 0.83; 95% confidence interval [CI], 0.63 to 1.09; P=0.18). Efficacy against the first and subsequent episodes of clinical malaria, as defined on the basis of various parasite-density thresholds, was approximately 20%. Efficacy against clinical malaria caused by parasites with AMA1 corresponding to that of the vaccine strain was 64.3% (hazard ratio, 0.36; 95% CI, 0.08 to 0.86; P=0.03). Local reactions and fever after vaccination were more frequent with the malaria vaccine. CONCLUSIONS: On the basis of the primary end point, the malaria vaccine did not provide significant protection against clinical malaria, but on the basis of secondary results, it may have strain-specific efficacy. If this finding is confirmed, AMA1 might be useful in a multicomponent malaria vaccine. (Funded by the National Institute of Allergy and Infectious Diseases and others; ClinicalTrials.gov number, NCT00460525.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870
Self-citationAlonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Milman, J., Mandomando, I., Spiessens, B., Guinovart, C., Espasa, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17223-1 · Cited by 752
Self-citationGenton, B., Betuela, I., Felger, I., Al‐Yaman, F., Anders, R. F., Saul, A., Rare, L., Baisor, M., Lorry, K., Brown, G. V., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/339342 · Cited by 523
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Bejon, P., Lusingu, J., Olotu, A., Leach, A., Lievens, M., Vekemans, J., Mshamu, S., Lang, T., Gould, J., Dubois, M.-C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807381 · Cited by 417
Self-citationOgutu, B. R., Apollo, O. J., McKinney, D., Okoth, W., Siangla, J., Dubovsky, F., Tucker, K., Waitumbi, J. N., Diggs, C., Wittes, J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004708 · Cited by 343
Self-citationGordon, D. M., McGovern, T. W., Krzych, U., Cohen, J. C., Schneider, I., LaChance, R., Heppner, D. G., Yuan, G., Hollingdale, M., Slaoui, M., et al. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1576 · Cited by 327
Self-citationKester, K. E., McKinney, D. A., Tornieporth, N., Ockenhouse, C. F., Heppner, D. G., Hall, T., Krzych, U., Delchambre, M., Voss, G., Dowler, M. G., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/318534 · Cited by 271
Self-citationA Research Agenda for Malaria Eradication: Vaccines
The malERA Consultative Group on Vaccines (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000398 · Cited by 264
HEPPNERJR, D., KESTER, K., OCKENHOUSE, C., TORNIEPORTH, N., OFORI, O., LYON, J., STEWART, V, DUBOIS, P., LANAR, D., & KRZYCH, U. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.142 · Cited by 192
Self-citationDutta, S., Lalitha, P. V., Ware, L. A., Barbosa, A., Moch, J. K., Vassell, M. A., Fileta, B. B., Kitov, S., Kolodny, N., Heppner, D. G., et al. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.3101-3110.2002 · Cited by 111
Self-citation
Cited by
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
Neafsey, D. E., Juraska, M., Bedford, T., Benkeser, D., Valim, C., Griggs, A., Lievens, M., Abdulla, S., Adjei, S., Agbenyega, T., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505819 · Cited by 422
The cellular and molecular basis for malaria parasite invasion of the human red blood cell
Cowman, A. F., Berry, D., & Baum, J. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201206112 · Cited by 370
Crompton, P. D., Moebius, J., Portugal, S., Waisberg, M., Hart, G., Garver, L. S., Miller, L. H., Barillas-Mury, C., & Pierce, S. K. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120220 · Cited by 317
The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum
Neafsey, D. E., Galinsky, K., Jiang, R. H. Y., Young, L., Sykes, S. M., Saif, S., Gujja, S., Goldberg, J. M., Young, S., Zeng, Q., et al. (2012) · Nature Genetics · doi:10.1038/ng.2373 · Cited by 275
Douglas, A. D., Williams, A. R., Illingworth, J. J., Kamuyu, G., Biswas, S., Goodman, A. L., Wyllie, D. H., Crosnier, C., Miura, K., Wright, G. J., et al. (2011) · Nature Communications · doi:10.1038/ncomms1615 · Cited by 272
Metadata
- Authors
- Thera, M. A., Doumbo, O. K., Coulibaly, D., Laurens, M. B., Ouattara, A., Kone, A. K., Guindo, A. B., Traore, K., Traore, I., Kouriba, B., Diallo, D. A., Diarra, I., Daou, M., Dolo, A., Tolo, Y., Sissoko, M. S., Niangaly, A., Sissoko, M., Takala-Harrison, S., Lyke, K. E., Wu, Y., Blackwelder, W. C., Godeaux, O., Vekemans, J., Dubois, M.-C., Ballou, W. R., Cohen, J., Thompson, D., Dube, T., Soisson, L., Diggs, C. L., House, B., Lanar, D. E., Dutta, S., Heppner, D. G., & Plowe, C. V.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-09-15
- Volume
- 365
- Issue
- 11
- Pages
- 1004-1013
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2026745968
- Cited by
- 370
- References
- 14
- FWCI
- 34.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Field Trial to Assess a Blood-Stage Malaria Vaccine. https://app.cochat.ai/papers/10.1056/nejmoa1008115
- The paper
- Thera, M. A., Doumbo, O. K., Coulibaly, D., Laurens, M. B., Ouattara, A., Kone, A. K., Guindo, A. B., Traore, K., Traore, I., Kouriba, B., Diallo, D. A., Diarra, I., Daou, M., Dolo, A., Tolo, Y., Sissoko, M. S., Niangaly, A., Sissoko, M., Takala-Harrison, S., . . . Plowe, C. V. (2011). A Field Trial to Assess a Blood-Stage Malaria Vaccine. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1008115
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.